Breaks Categories: News

TuesdayMar 26, 2019 10:33 am

NetworkNewsBreaks – Golden Developing Solutions, Inc. (DVLP) Issues Shareholder Update and Steep Growth Potential Following Recent CBD Acquisition

Emerging leader in the cannabis, hemp, and cannabidiol (“CBD”) marketplace Golden Developing Solutions (OTC: DVLP) this morning provided a shareholder update via a letter from its CEO. According to the update, the company has gained traction in the cannabis space as a service provider with its popular Where’s Weed app and portal, as well as expanded its market footprint to move into the CBD space with its Where’s CBD portal. This sets the stage for what the company believes could be a true gamechanger through its recent acquisition of Infusionz, LLC (“CBD Infusionz”), a premium manufacturer of high quality CBD…

Continue Reading

TuesdayMar 26, 2019 10:02 am

NetworkNewsBreaks – BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) Closes First Tranche of Private Placement; Plans to Release Early Efficacy Data of Lead Candidate in Combination Study

BriaCell Therapeutics (OTCQB: BCTXF) (TSX.V: BCT), a biotechnology company developing targeted, safe treatments for cancer, this morning announced that it has closed the first tranche of a non-brokered private placement of up to 20,000,000 of its common shares, each at a price of C$0.10, for gross proceeds of up to approximately C$2,000,000. According to the update, the first tranche comprised of 7,500,000 common shares, each at a price of C$0.10, for gross proceeds of C$750,000. The closing of the second and final tranche of the offering is scheduled to occur in late March 2019. BriaCell intends to use net proceeds…

Continue Reading

TuesdayMar 26, 2019 9:35 am

NetworkNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Posts Preliminary 2018 Unaudited Financial Results; Reports Estimated Revenues of $8.4M

Plus Products (CSE: PLUS) (OTCQB: PLPRF) this morning reported its unaudited revenue estimate for the fiscal period ended December 31, 2018 of $8.4 million, representing an enormous growth of 684% from fiscal 2017 revenues of $1.1 million. Additionally, the company reported revenue estimates of $3.4 million for the fourth quarter of 2018, an increase of about 32% over the third quarter of 2018. PLUS attributes the surge primarily to sales of its concentrated brand portfolio of four full-time SKUs and one rotating seasonal. The company’s unaudited cash balance rose from $11.1 million as of September 30, 2018 to $22.9 million…

Continue Reading

MondayMar 25, 2019 3:46 pm

NetworkNewsBreaks – Kontrol Energy Corp. (CSE: KNR) (OTCQB: KNRLF) (FSE: 1K8) and Toyota Tsusho Canada Inc. Enter Partnership to Provide Technology Solutions for North American Markets

Kontrol Energy (CSE: KNR) (OTCQB: KNRLF) (FSE: 1K8), a leader in the energy efficiency sector, today announced its entry into an agreement with Toyota Tsusho Canada Inc. (“TTCI”), a wholly owned subsidiary of Toyota Tsusho America, Inc., to implement Smart Factory technology solutions. Under the agreement, Kontrol and TTCI intend to establish a joint venture company to provide technology solutions that combine Kontrol's Internet of Things (“IoT”) hardware and software solutions with TTCI's existing production, operating improvement platforms, and power generation / HVAC products for the North American automobile and parts OEMs. “We are pleased to enter a significant new…

Continue Reading

MondayMar 25, 2019 12:22 pm

NetworkNewsBreaks – Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Adds New Tinctures to its CBD+ Wellness Line

Wildflower Brands (CSE: SUN) (OTCQB: WLDFF) today announced the addition of the Pure and Pure Plus tinctures to its CBD+ Wellness line of products. Pure and Pure Plus tinctures, formulated with hemp-derived CBD, milk thistle and hemp seed oil, are designed to provide relief from inflammation and support healthy liver and heart function. Based on the success of its existing tinctures, WLDFF has added hemp seed oil to the new offering for optimal omega-3 and omega-6 fatty acid ratios in solvent-free formulations that can be taken sublingually via a dropper or used in food and beverage preparation. “Consumers are drawn…

Continue Reading

MondayMar 25, 2019 11:19 am

NetworkNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Initiates Growers’ Circle Launch, Domestic Sales to Patients Across Canada

Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF) this morning announced that sales of its certified-organic cannabis have started with national distribution to medical patients. Per the update, a select group of patients across Canada called The Growers' Circle now receives TGOD's first certified-organic flower. The Growers' Circle launch is a limited production rollout of TGOD’s premium product, allowing the company to perfect its distribution ahead of its production ramp-up and scaled rollout this year. “The launch of the Growers' Circle is another significant moment in TGOD's commercial story,” TGOD Director and Chief Executive…

Continue Reading

MondayMar 25, 2019 10:56 am

NetworkNewsBreaks – Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) to Expand to Florida Market Through Investment in Vertically-Integrated Cannabis Applicant

British Columbia-based fully-integrated cannabis company Choom Holdings (CSE: CHOO) (OTCQB: CHOOF) this morning announced its intended expansion into Florida following its strategy to become a multi-state operator. According to the update, Choom, through its wholly owned subsidiary, Choom Holdings USA Inc., has entered a letter of intent ("LOI") to purchase a 95 percent equity interest in a Florida-based vertically-integrated cannabis applicant. “We are very excited to be expanding into Florida and to bring Choom's medical brand into that market.  Florida's medical marijuana program is a very attractive opportunity for us seeing that it allows for vertically-integrated operations and it has…

Continue Reading

MondayMar 25, 2019 10:06 am

NetworkNewsBreaks – Canopy Rivers Inc.’s (TSX.V: RIV) (OTC: CNPOF) Spot Therapeutics Receives Health Canada Cultivation License, Triggering Long-Term Cash Flow

Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) today announced receipt of a Health Canada cultivation license for Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) and its portfolio company, Spot Therapeutics Inc., for its Fredericton-based production and distribution facility. Per the update, the newly licensed facility will operate under the flagship Tweed banner, and the cultivation license initiates a long-term (25-year) cash flow stream anticipated to be approximately $2.85 million per year with commencement expected to begin in September 2019. “The long-term income stream from Spot, combined with our existing royalty portfolio, will further stabilize Canopy Rivers’ operating cash flow profile and…

Continue Reading

MondayMar 25, 2019 9:43 am

NetworkNewsBreaks – VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) Announces Health Canada Approval for Canna Farms Subsidiary to Expand Hope Facility, Double BC Production

VIVO Cannabis (TSX.V: VIVO) (OTCQX: VVCIF) on Friday announced receipt of approval from Health Canada for its wholly-owned subsidiary, Canna Farms Ltd., to begin cultivation in the expansion of its Yale Road facility in Hope, BC, resulting in its doubled cultivation capacity in the province. According to the update, production, product development space and automated packaging equipment is included in the expansion that is expected to be incorporated into the facility and brought on-line in mid 2019. The company expects to commence cultivation in the expanded area in May 2019. “Today's approval of the Hope, British Columbia expansion is in…

Continue Reading

FridayMar 22, 2019 2:17 pm

NetworkNewsBreaks – Altimmune, Inc. (NASDAQ: ALT) Closes $14M Registered Direct Offering

Altimmune (NASDAQ: ALT), a clinical-stage immunotherapeutics company, recently announced the closing of the sale of common units and pre-funded units for a total of 4,361,370 units in a registered direct offering with two institutional investors resulting in gross proceeds to Altimmune of $14 million. In a March 8, 2019 news release Altimmune disclosed that as of December 31, 2018, it held roughly $34.4 million in cash, cash equivalents and restricted cash. The company plans to use its cash on hand combined with the net proceeds of approximately $12.7 million from this offering toward the continued advancement and development of its…

Continue Reading